In ovarian cancer, WWP2 mutations significantly affect survival, with patients harboring WWP2 mutations exhibiting a median survival time of 12 months compared to 24 months in those without the mutation (Li Z et al., 2024). This evidence concerns the gene WWP2 and ovarian cancer.